Screener / SEC EDGAR /CIK 0001520262 /10-K filed Feb 25, 2026, compared with Feb 12, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Alkermes plc. ALKS

Compare with peers Embed
Investor presentations

22 kept

8-K exhibits, EX-99
Latest presentation Nov 3, 2026 Third Quarter 2026Financial Results & Business Update November 3, 2026 Exhibit 99.2 Forwar…
Presentations kept 22 oldest Nov 15, 2023
8-Ks read 36 with item 7.01, 2.02 or 8.01, since May 24, 2017
Presentations filed each year
  1. 12023
  2. 72024
  3. 92025
  4. 52026

Every presentation

Newest first · linked to sec.gov

FiledWhat it is
Nov 3, 2026 Presentation Third Quarter 2026Financial Results & Business Update Novemb… As filed · filing
Jul 28, 2026 Presentation Second Quarter 2026Financial Results & Business Update July … As filed · filing
May 5, 2026 Presentation First Quarter 2026Financial Results & Business Update May 5,… As filed · filing
Feb 25, 2026 Presentation Fourth Quarter and Year-End 2025 Financial Results & Busines… As filed · filing
Jan 12, 2026 Presentation Alkermes 2026: Driving Profitable Growth in Neuroscience and… As filed · filing
Nov 12, 2025 Presentation Vibrance-2 Phase 2 Study of Alixorexton in Patients with Nar… As filed · filing
Oct 28, 2025 Presentation Third Quarter 2025Financial Results & Business Update Octobe… As filed · filing
Oct 22, 2025 Presentation Proposed Acquisition of Avadel Pharmaceuticals plc October 2… As filed · filing
Sep 8, 2025 Presentation Vibrance-1 Alixorexton Phase 2 Study in Patients with Narcol… As filed · filing
Sep 8, 2025 Presentation Table of Contents Important Information About This Document … As filed · filing
Jul 29, 2025 Presentation Second Quarter 2025Financial Results & Business Update July … As filed · filing
May 1, 2025 Presentation First Quarter 2025Financial Results & Business Update May 1,… As filed · filing
Feb 12, 2025 Presentation Fourth Quarter and Year-End 2024 Financial Results & Busines… As filed · filing
Jan 13, 2025 Presentation Alkermes 2025 Richard Pops Chief Executive Officer 43rd Annu… As filed · filing
Dec 2, 2024 Presentation Alkermes 2024: Profitable, Pure-play Neuroscience Company De… As filed · filing
Oct 24, 2024 Presentation Third Quarter 2024 Financial Results & Business Update Octob… As filed · filing
Oct 9, 2024 Presentation Alkermes Orexin Portfolio Strategy Review October 9, 2024 Ex… As filed · filing
Jul 24, 2024 Presentation Second Quarter 2024 Financial Results & Business Update July… As filed · filing
May 1, 2024 Presentation First Quarter 2024 Financial Results & Business Update May 1… As filed · filing
Feb 15, 2024 Presentation Fourth Quarter and Year-End 2023 Financial Results & Busines… As filed · filing
Jan 8, 2024 Presentation Alkermes 2024: Profitable, Pure-play Neuroscience Company Ri… As filed · filing
Nov 15, 2023 Presentation Alkermes Corporate Presentation November 2023 Exhibit 99.2 F… As filed · filing
Show the other 10 presentations

A presentation is an 8-K exhibit that SEC's index or the document's own title calls a presentation, investor update or earnings supplement. Decks a company shows only on its own website are not filed with SEC and are not here.

Sources

The exhibits of the company's 8-Ks (SEC EDGAR) that are slide decks. Each row links to the filing on sec.gov.

Also

Earnings releases: the text of each quarter's results release.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALKS/export.csv") into a cell.

Next:Said vs did
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.